These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 16715130)

  • 1. A ubiquitin ligase, skeletrophin, is a negative regulator of melanoma invasion.
    Takeuchi T; Adachi Y; Sonobe H; Furihata M; Ohtsuki Y
    Oncogene; 2006 Nov; 25(53):7059-69. PubMed ID: 16715130
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Skeletrophin, a novel ubiquitin ligase to the intracellular region of Jagged-2, is aberrantly expressed in multiple myeloma.
    Takeuchi T; Adachi Y; Ohtsuki Y
    Am J Pathol; 2005 Jun; 166(6):1817-26. PubMed ID: 15920166
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Skeletrophin, a novel RING molecule controlled by the chromatin remodeling complex, is downregulated in malignant melanoma.
    Takeuchi T; Adachi Y; Ohtsuki Y
    DNA Cell Biol; 2005 May; 24(5):339-44. PubMed ID: 15869411
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synergistic silencing by promoter methylation and reduced AP-2α transactivation of the proapoptotic HRK gene confers apoptosis resistance and enhanced tumor growth.
    Xu M; Chen X; Chen N; Nie L; Li X; Li Q; Zeng H; Zhou Q
    Am J Pathol; 2013 Jan; 182(1):84-95. PubMed ID: 23159945
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gene methylation in gastric cancer.
    Qu Y; Dang S; Hou P
    Clin Chim Acta; 2013 Sep; 424():53-65. PubMed ID: 23669186
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Down-regulation of a novel actin-binding molecule, skeletrophin, in malignant melanoma.
    Takeuchi T; Heng HH; Ye CJ; Liang SB; Iwata J; Sonobe H; Ohtsuki Y
    Am J Pathol; 2003 Oct; 163(4):1395-404. PubMed ID: 14507647
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bone morphogenic proteins are overexpressed in malignant melanoma and promote cell invasion and migration.
    Rothhammer T; Poser I; Soncin F; Bataille F; Moser M; Bosserhoff AK
    Cancer Res; 2005 Jan; 65(2):448-56. PubMed ID: 15695386
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure and regulation of the versican promoter: the versican promoter is regulated by AP-1 and TCF transcription factors in invasive human melanoma cells.
    Domenzain-Reyna C; Hernández D; Miquel-Serra L; Docampo MJ; Badenas C; Fabra A; Bassols A
    J Biol Chem; 2009 May; 284(18):12306-17. PubMed ID: 19269971
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of PLZF in melanoma progression.
    Felicetti F; Bottero L; Felli N; Mattia G; Labbaye C; Alvino E; Peschle C; Colombo MP; Carè A
    Oncogene; 2004 Jun; 23(26):4567-76. PubMed ID: 15077196
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epigenetic inactivation of RAS association domain family protein 1 (RASSF1A) in malignant cutaneous melanoma.
    Spugnardi M; Tommasi S; Dammann R; Pfeifer GP; Hoon DS
    Cancer Res; 2003 Apr; 63(7):1639-43. PubMed ID: 12670917
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aberrant CpG methylation of the TFAP2A gene constitutes a mechanism for loss of TFAP2A expression in human metastatic melanoma.
    Hallberg AR; Vorrink SU; Hudachek DR; Cramer-Morales K; Milhem MM; Cornell RA; Domann FE
    Epigenetics; 2014 Dec; 9(12):1641-7. PubMed ID: 25625848
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RASSF8 regulates progression of cutaneous melanoma through nuclear factor-κb.
    Wang J; Hua W; Huang SK; Fan K; Takeshima L; Mao Y; Hoon DS
    Oncotarget; 2015 Oct; 6(30):30165-77. PubMed ID: 26334503
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Loss of AP-2 results in downregulation of c-KIT and enhancement of melanoma tumorigenicity and metastasis.
    Huang S; Jean D; Luca M; Tainsky MA; Bar-Eli M
    EMBO J; 1998 Aug; 17(15):4358-69. PubMed ID: 9687504
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Ets-1 transcription factor is involved in the development and invasion of malignant melanoma.
    Rothhammer T; Hahne JC; Florin A; Poser I; Soncin F; Wernert N; Bosserhoff AK
    Cell Mol Life Sci; 2004 Jan; 61(1):118-28. PubMed ID: 14704859
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epigenetic silencing of Aristaless-like homeobox-4, a potential tumor suppressor gene associated with lung cancer.
    Liu WB; Han F; Du XH; Jiang X; Li YH; Liu Y; Chen HQ; Ao L; Cui ZH; Cao J; Liu JY
    Int J Cancer; 2014 Mar; 134(6):1311-22. PubMed ID: 24037716
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transcriptional activation of the hepatocyte growth factor receptor (c-met) gene by its ligand (hepatocyte growth factor) is mediated through AP-1.
    Seol DW; Chen Q; Zarnegar R
    Oncogene; 2000 Feb; 19(9):1132-7. PubMed ID: 10713700
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pre-B-cell leukemia transcription factor 1 is a major target of promyelocytic leukemia zinc-finger-mediated melanoma cell growth suppression.
    Shiraishi K; Yamasaki K; Nanba D; Inoue H; Hanakawa Y; Shirakata Y; Hashimoto K; Higashiyama S
    Oncogene; 2007 Jan; 26(3):339-48. PubMed ID: 16862184
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RaLP, a new member of the Src homology and collagen family, regulates cell migration and tumor growth of metastatic melanomas.
    Fagiani E; Giardina G; Luzi L; Cesaroni M; Quarto M; Capra M; Germano G; Bono M; Capillo M; Pelicci P; Lanfrancone L
    Cancer Res; 2007 Apr; 67(7):3064-73. PubMed ID: 17409413
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endothelin-1 and endothelin-3 promote invasive behavior via hypoxia-inducible factor-1alpha in human melanoma cells.
    Spinella F; Rosanò L; Di Castro V; Decandia S; Nicotra MR; Natali PG; Bagnato A
    Cancer Res; 2007 Feb; 67(4):1725-34. PubMed ID: 17308114
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Frequent alterations of Ras signaling pathway genes in sporadic malignant melanomas.
    Reifenberger J; Knobbe CB; Sterzinger AA; Blaschke B; Schulte KW; Ruzicka T; Reifenberger G
    Int J Cancer; 2004 Apr; 109(3):377-84. PubMed ID: 14961576
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.